MiRNA-SARS-CoV-2 dialogue and prospective anti-COVID-19 therapies M Panda, E Kalita, S Singh, K Kumar, A Rao, VK Prajapati Life Sciences 305, 120761, 2022 | 41 | 2022 |
Nanobody-peptide-conjugate (NPC) for passive immunotherapy against SARS-CoV-2 variants of concern (VoC): a prospective pan-coronavirus therapeutics M Panda, E Kalita, S Singh, K Kumar, VK Prajapati Molecular Diversity 27 (6), 2577-2603, 2023 | 8 | 2023 |
Mechanism of cell cycle regulation and cell proliferation during human viral infection M Panda, E Kalita, A Rao, VK Prajapati Advances in Protein Chemistry and Structural Biology 135, 497-525, 2023 | 4 | 2023 |
The interplay between circadian clock and viral infections: A molecular perspective E Kalita, M Panda, VK Prajapati Advances in Protein Chemistry and Structural Biology 137, 293-330, 2023 | 3 | 2023 |
Pharmacoinformatics-based screening and construction of a neutralizing anti-SARS-CoV-2 camelidae nanobody drug conjugate E Kalita, M Panda, S Dhar, S Mehrotra, VK Prajapati Molecular Diversity, 1-19, 2025 | | 2025 |
Comprehensive analysis of the Kinetoplastea intron landscape reveals a novel intron-containing gene and the first exclusively trans-splicing eukaryote AY Kostygov, K Skýpalová, N Kraeva, E Kalita, C McLeod, V Yurchenko, ... BMC biology 22 (1), 1-20, 2024 | | 2024 |
Viral mimicry and endocrine system: Divulging the importance in host-microbial crosstalk. E Kalita, M Panda, A Rao, RK Pandey, VK Prajapati Advances in Protein Chemistry and Structural Biology 142, 421-436, 2024 | | 2024 |
Application of functional proteomics in understanding RNA virus-mediated infection M Panda, E Kalita, S Singh, A Rao, VK Prajapati Advances in Protein Chemistry and Structural Biology 138, 301-325, 2024 | | 2024 |
Exploring the role of secretory proteins in the human infectious diseases diagnosis and therapeutics E Kalita, M Panda, A Rao, VK Prajapati Advances in Protein Chemistry and Structural Biology 133, 231-269, 2023 | | 2023 |